Preformed HLA Donor-Specific Antibodies Disappearance After Kidney Transplantation: Significance and Comparison with Persistent DSA

被引：0
|
作者：
Redondo, D. [1 ]
Perez-Saez, M. [1 ]
Mir, M. [1 ]
Gimeno, J. [1 ]
Garcia, C. [2 ]
Hernandez, J. [2 ]
Yalamos, J. [3 ]
Pascual, J. [1 ]
Crespo, M. [1 ]
机构：
[1] Hosp del Mar, Nephrol Dept, Barcelona, Spain
[2] Lab Referencia Catalunya, Barcelona, Spain
[3] IMIM, Barcelona, Spain
来源：
AMERICAN JOURNAL OF TRANSPLANTATION | 2017年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
B76
引用
收藏
页码：537 / 538
页数：2
相关论文
共 50 条
  • [21] STRENGTH/SPECIFICITY OF DE NOVO HLA DONOR-SPECIFIC ANTIBODIES IN KIDNEY TRANSPLANTATION: CLINICAL SIGNIFICANCE
    Piazza, Antonina
    Poggi, Elvira
    Ozzella, Giuseppina
    Adorno, Domenico
    HUMAN IMMUNOLOGY, 2009, 70 : S64 - S64
  • [22] Pretransplant Donor-Specific HLA Antibodies: Risk Factors and Outcomes after Kidney Transplantation
    Kanter Berga, J.
    Gavela Martinez, E.
    Puig Alcaraz, N.
    Sancho Calabuig, A.
    Pallardo Mateu, L.
    TRANSPLANTATION, 2012, 94 (10) : 63 - 63
  • [23] THE CLINICAL UTILITY OF PREFORMED C1Q-BINDING DONOR-SPECIFIC HLA ANTIBODIES IN KIDNEY TRANSPLANTATION
    Lee, Sua
    Ko, Eun Jeong
    Chung, Byung Ha
    Yang, Chul Woo
    TRANSPLANTATION, 2020, 104 (09) : S3 - S3
  • [24] Donor-Specific HLA Antibodies in a Cohort Comparing Everolimus with Cyclosporine After Kidney Transplantation
    Liefeldt, L.
    Brakemeier, S.
    Glander, P.
    Waiser, J.
    Lachmann, N.
    Schoenemann, C.
    Zukunft, B.
    Illigens, P.
    Schmidt, D.
    Wu, K.
    Rudolph, B.
    Neumayer, H. -H.
    Budde, K.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2012, 12 (05) : 1192 - 1198
  • [25] RE: Donor-specific HLA antibodies: Risk factors and outcomes after kidney transplantation
    Nunes, A. A.
    de Mello, Luane Marques
    TRANSPLANTATION PROCEEDINGS, 2013, 45 (01) : 446 - 447
  • [26] The natural history of de novo donor-specific HLA antibodies after kidney transplantation
    Lopez del Moral, Covadonga
    Wu, Kaiyin
    Naik, Marcel
    Osmanodja, Bilgin
    Akifova, Aylin
    Lachmann, Nils
    Stauch, Diana
    Hergovits, Sabine
    Choi, Mira
    Bachmann, Friederike
    Halleck, Fabian
    Schrezenmeier, Eva
    Schmidt, Danilo
    Budde, Klemens
    FRONTIERS IN MEDICINE, 2022, 9
  • [27] INPACT OF PREFORMED DSA C1Q-BINDING DONOR-SPECIFIC ANTI-HLA ANTIBODY IN KIDNEY TRANSPLANTATION
    Kurihara, Kei
    Kaku, Keizo
    Noguchi, Hiroshi
    Okabe, Yasuhiro
    Nakamura, Masafumi
    TRANSPLANT INTERNATIONAL, 2017, 30 : 471 - 471
  • [28] Living donor liver transplantation (LDLT) for patients with preformed donor-specific antibodies (DSA) - single institution experience
    Takahashi, R.
    Akamatsu, N.
    Ichida, A.
    Nakazawa, A.
    Matsumura, M.
    Togashi, J.
    Ishizawa, T.
    Kaneko, J.
    Arita, J.
    Hasegawa, K.
    TRANSPLANTATION, 2021, 105 (08) : 108 - 108
  • [29] CLINICAL SIGNIFICANCE OF COMPLEMENT-BINDING DONOR-SPECIFIC ANTIBODIES AFTER KIDNEY TRANSPLANTATION
    Rodova, Marketa
    Fornbaumova, Iva
    Janatova, Katerina
    Sekerkova, Zuzana
    Slavcev, Antonij
    HLA, 2017, 89 (06) : 404 - 405
  • [30] CLINICAL RELEVANCE OF DE NOVO DONOR-SPECIFIC HLA ANTIBODIES (DSA) IN RENAL TRANSPLANTATION
    Sommer, Florian
    Kauke, Teresa
    Anthuber, Matthias
    TRANSPLANT INTERNATIONAL, 2017, 30 : 356 - 356
12345